Glass Lewis and Egan-Jones Advise Tiptree Shareholders to Oppose DB Merger
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
- Shareholder Action: Veradace Partners, holding 5.1% of Tiptree's common stock, has announced its opposition to the proposed sale of Fortegra to DB Insurance.
- Advisory Firms' Recommendations: Glass Lewis and Egan-Jones have advised Tiptree shareholders to vote against the sale at the upcoming special meeting scheduled for December 3.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TIPT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TIPT
About TIPT
Tiptree Inc. is a holding company engaged in allocating capital to select small and middle market companies across industries. The Company invests across a variety of industries and asset types, including the insurance, asset management, specialty finance, real estate, and shipping sectors. The Company’s segments include Insurance and Mortgage. The Insurance segment consists of Fortegra Group, LLC (Fortegra), which is a multinational specialty insurance company focused on underwriting complex and niche risks in underserved markets. Fortegra is an underwriting-focused company, with expertise within the admitted and excess and surplus (E&S) insurance lines and capital light fee-based services markets. It owns a diversified group of businesses and investments that are owned and managed separately as Tiptree Capital, which includes its mortgage segment operations. Tiptree Capital consists primarily of its mortgage operations and principal investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tiptree Shareholders Approve Merger Agreement with Fortegra
- Merger Approval: At the Special Meeting, approximately 81% of Tiptree shareholders voted in favor of the merger agreement with Fortegra and DB Insurance, marking a significant milestone in Tiptree's value creation and expected to enhance long-term shareholder value.
- Clear Transaction Structure: The merger will be executed through a wholly owned subsidiary of DB merging with Fortegra, ensuring a smooth transaction process and simplifying subsequent integration efforts.
- Expected Completion Timeline: Tiptree anticipates closing the merger in mid-2026, subject to customary closing conditions including necessary regulatory approvals, which will lay a foundation for future growth.
- Commitment to Transparency: Tiptree will file a Form 8-K with the SEC to report the final voting results from the Special Meeting, demonstrating the company's commitment to shareholder transparency and compliance.
Continue Reading
Veradace Urges Tiptree Shareholders to Vote Against Fortegra Sale
- Shareholder Opposition: Veradace Partners L.P., holding 5.1% of Tiptree Inc., urges shareholders to vote against the proposed sale of Fortegra to DB Insurance at the special meeting on December 3, 2025. This proposal is viewed as a rushed deal that overlooked superior alternatives.
- Management Conflicts of Interest: Glass Lewis and Egan-Jones highlight that the deal structure raises questions about management incentives, potentially allowing management to continue siphoning value from shareholders instead of providing immediate payouts. This structure places nearly $1 billion in proceeds without a clear capital return plan, increasing shareholder risk.
- Negative Market Reaction: Following the announcement of the transaction, Tiptree's stock price dropped over 20%, indicating a lack of confidence from the market regarding the deal. Egan-Jones also noted that the deal leaves Tiptree with nearly $1 billion in unallocated cash, giving management discretion to redeploy capital at will.
- Allegations of Analytical Errors: Veradace claims that Institutional Shareholder Services' analysis contains several material errors, failing to fully assess the deal's valuation and potential risks. The conclusions drawn are seen as based on irrelevant factors, neglecting the long-term value implications for shareholders.
Continue Reading